评估产后出血的特兰胺酸剂量策略:怀孕个体的人口药理动力学方法
Allison Dunn1, Mina Felfeli2, Sebastian M Seifert3
1Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, MD, USA.
Journal of clinical pharmacology
|May 19, 2025
概括
固定剂量的特兰胺酸 (TXA) 是有效的预防和治疗产后出血 (PPH). 肌内TXA是一种可行的静脉注射替代品,可以达到类似的暴露目标.
科学领域:
- 药理学 药理学是指药理学的学科.
- 产科 产科 产科 产科 产科
- 临床药房 临床药房
背景情况:
- 特兰胺酸 (TXA) 对于治疗产后出血 (PPH) 是至关重要的.
- 在孕妇中优化TXA剂量方案需要进一步调查.
- 了解TXA的药理动力学 (PK) 对于有效的PPH治疗和预防至关重要.
研究的目的:
- 在怀孕个体的多样化人群中描述TXA PK.
- 评估TXA的基于体重的剂量的必要性.
- 为了比较通过不同TXA给药途径 (IV,IM,口服) 达到的暴露目标.
主要方法:
- 使用非线性混合效应建模 (Pumas) 进行人口PK分析.
- 利用了4项临床试验的数据,涉及211名孕妇参与者.
- 开发了一种具有第一阶段淘汰和吸收的两部分模型.
主要成果:
- 实际体重是一个显著的共同变量,但解释了TXA PK的有限变化.
- 模拟显示固定剂量和基于体重的剂量之间的暴露差异很小.
- 肌内TXA显示了与静脉注射相比较的暴露指标.
结论:
- 对于孕妇来说,支持TXA的固定剂量方案,简化了管理.
- 肌内TXA为PPH管理提供了静脉注射途径的实用和有效替代方案.
- 进一步的研究可能会完善TXA剂量策略,以改善PPH结果.
相关概念视频
Analysis of Population Pharmacokinetic Data
204
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
204
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
36
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
36
Nonlinear Pharmacokinetics: Overview
225
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
225
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
578
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
578
Renal Failure: Dose Adjustments
50
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
50


